New Frontiers on Genetic Research & Advanced Techniques December 14-15, 2020 Tokyo, Japan

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients

EURO GENETIC ENGINEERING 2020

Mr. Deven Patel, the CEO, President and Cofounder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A. GIOSTAR was formed with the vision to provide affordable stem cell-based therapies to the masses around the world suffering from degenerative or genetic diseases and unable to afford today’s high cost of the treatment.

Euro Genetic Engineering 2020

SIMONE PACINI has completed his Ph.D. in 1997. Until 2003 he was active in onomatology and responsible for flow cytometry and cell sorting facility. Later, his studies focused on clinical use of MSCs and participated actively on isolation of a novel progenitor of MSC in adult human bone marrow. He is currently working in collaboration reputed Universities and Medical Colleges. Actaually, he is lab director of the “Michele Cavaliere Laboratories for Cell Therapy ” at the University of Pisa. He has published more than 40 papers in reputed journals and he is an editorial board member of the Frontiers in Cell Developmental Biology journal.

Euro Genetic Engineering 2020